137 related articles for article (PubMed ID: 35451560)
21. MYC-Induced Upregulation of Lncrna ELFN1-AS1 Contributes to Tumor Growth in Colorectal Cancer via Epigenetically Silencing TPM1.
Li C; Hong S; Hu H; Liu T; Yan G; Sun D
Mol Cancer Res; 2022 Nov; 20(11):1697-1708. PubMed ID: 35857351
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA TNK2 AS1/microRNA-125a-5p axis promotes tumor growth and modulated phosphatidylinositol 3 kinase/AKT pathway.
Guo L; Ma H; Kong Y; Leng G; Liu G; Zhang Y
J Gastroenterol Hepatol; 2022 Jan; 37(1):124-133. PubMed ID: 34494305
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
24. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
[TBL] [Abstract][Full Text] [Related]
25. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
Cui S
J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression.
Zhang P; Dong Q; Zhu H; Li S; Shi L; Chen X
Gene; 2019 May; 696():1-9. PubMed ID: 30735718
[TBL] [Abstract][Full Text] [Related]
27. ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer.
Jie Y; Ye L; Chen H; Yu X; Cai L; He W; Fu Y
Bioengineered; 2020 Dec; 11(1):872-882. PubMed ID: 32779991
[TBL] [Abstract][Full Text] [Related]
28. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
[TBL] [Abstract][Full Text] [Related]
29. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
31. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer.
Yang KD; Wang Y; Zhang F; Li QL; Luo BH; Feng DY; Zeng ZJ
Mol Cell Biochem; 2022 Nov; 477(11):2493-2505. PubMed ID: 35588343
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
34. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p.
Zhang C; Lian H; Xie L; Yin N; Cui Y
Biol Chem; 2020 Aug; 401(9):1053-1061. PubMed ID: 32229685
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769-5p.
Yu L; Luan W; Feng Z; Jia J; Wu Z; Wang M; Li F; Li Z
Dig Liver Dis; 2021 Feb; 53(2):238-244. PubMed ID: 32952069
[TBL] [Abstract][Full Text] [Related]
36. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer.
Jiang K; Zhi XH; Ma YY; Zhou LQ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9890-9899. PubMed ID: 31799657
[TBL] [Abstract][Full Text] [Related]
38. STAT3-induced ZBED3-AS1 promotes the malignant phenotypes of melanoma cells by activating PI3K/AKT signaling pathway.
Wang Y; Lou N; Zuo M; Zhu F; He Y; Cheng Z; Wang X
RNA Biol; 2021 Oct; 18(sup1):355-368. PubMed ID: 34241580
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA ncRuPAR regulates gastric cancer cell proliferation and apoptosis via phosphoinositide 3-kinase/protein kinase B signaling.
Xu R; Yu J; Song S; Sun D; Xiu L; Xu J; Zhao J; Liu X; Ji Q; Yue X
Int J Med Sci; 2022; 19(13):1835-1846. PubMed ID: 36438913
[No Abstract] [Full Text] [Related]
40. Long Noncoding RNA EGFR-AS1 Promotes Cell Proliferation by Increasing EGFR mRNA Stability in Gastric Cancer.
Hu J; Qian Y; Peng L; Ma L; Qiu T; Liu Y; Li X; Chen X
Cell Physiol Biochem; 2018; 49(1):322-334. PubMed ID: 30138934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
